067080 — Dae Hwa Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Dae Hwa Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	9,072	-2,483	1,962	1,221	-514
Depreciation
Amortisation
Non-Cash Items	2,987	9,216	5,593	8,535	5,763
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-17,613	-9,500	-1,927	-6,251	-11,709
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	108	2,901	10,447	8,046	-590
Capital Expenditures	-15,077	-10,384	-14,395	-31,937	-10,980
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	11,507	-1,424	893	6,690	-4,254
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-3,570	-11,807	-13,503	-25,247	-15,234
Financing Cash Flow Items	174	-14.7	-597	—	14
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-89.9	9,620	3,647	16,324	17,048
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-3,552	713	591	-877	1,224